Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)

This study has been completed.
Information provided by (Responsible Party):
Ji-youn Han, National Cancer Center, Korea Identifier:
First received: March 26, 2007
Last updated: September 15, 2011
Last verified: September 2011